These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2005-004103-10||Randomized, open labeled, multi center, active controlled, parallel 28 days safety and bioavailability study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS in cy...||2008-01-07||not-yet-due|
|Exempt||2007-000959-33||Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow® versus TOBI® nebulized with PARI LC PLUS® in subjects with CF||2007-12-18||not-yet-due|
|Listed as ongoing, but also has a completion date and reported results||2008-003800-73||A phase III, multicentre, randomised, double-blind, placebo controlled clinical trial to investigate the efficacy and safety of 10 or 20 mg/day aerosolised liposomal ciclosporin A (L-CsA) versus aeros...||2013-06-27||bad-data|
|Not reported||2008-003801-15||A phase II, randomised, double-blind, placebo controlled, parallel group, dose-finding clinical trial to investigate the efficacy and safety of 10 and 20 mg/day aerosolised liposomal ciclosporin A (L-...||2009-11-11||due-trials|
|Exempt||2010-023235-41||A comparative, randomised, two period, multi-center, cross-over 14 weeks bioequivalence study of Tobramycin PARI (T100) versus TOBI® (Novartis) in cystic fibrosis patients with bronchopulmonary chroni...||2012-06-26||not-yet-due|
|Listed as ongoing, but also has a completion date and reported results||2011-004304-38||A long-term safety follow-up study of L-CsA therapy for patients who participated in study 12011.201 and volunteered to continue or to cross-over to L-CsA inhalation therapy||2013-06-26||bad-data|
|Ongoing||2013-002414-12||A randomised, open, controlled pilot study to investigate the efficacy and safety of Buparid/PARI SINUS versus Budes® Nasal Spray in the therapy of Chronic Rhinosinusitis (CRS) with polyposis nasi in ...||not-yet-due|
|Ongoing||2013-002421-30||A randomised, open, controlled pilot study to investigate the potential of||not-yet-due|